DOCSLIB.ORG

Communicable Disease Case Counts 2014-2018

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Communicable Disease Case Counts 2014-2018 Report 4: Table of Diseases Comparing A Given Timeframe for Past 5 Years Case Types: Individual Cases Only Case Status: Confirmed, Probable Year: 2014-2018 Investigation Status: Completed Display Interval: By Year Jurisdictions: Mid-Michigan District Report Type: Counts Disease Group Disease 2014 2015 2016 2017 2018 Total AIDS/HIV AIDS, Aggregate 0 0 0 0 0 0 HIV/AIDS, Adult 3 2 0 0 0 5 HIV/AIDS, Pediatric 0 0 0 0 0 0 Subtotal 3 2 0 0 0 5 Foodborne Amebiasis 1 0 0 1 0 2 Botulism - Foodborne 0 0 0 0 0 0 Campylobacter 14 31 17 20 12 94 Cryptosporidiosis 7 6 13 15 7 48 Escherichia coli 0157:H7 (Pre-2011)* 0 0 0 0 0 0 Giardiasis 19 10 8 14 3 54 Listeriosis 0 0 0 0 0 0 Listeriosis (2014- 2017)* 1 0 0 0 0 1 Listeriosis (Pre-2014)* 0 0 0 0 0 0 Norovirus 4 1 13 7 5 30 Paratyphoid Fever 0 0 0 0 0 0 Salmonellosis 10 12 24 20 20 86 Shiga toxin, E. Coli, Non O157 (Pre- 2011)* 0 0 0 0 0 0 Shiga toxin, E. Coli, Unsp (Pre-2011)* 0 0 0 0 0 0 Shiga toxin-producing Escherichia coli -- (STEC) 4 1 4 0 3 12 Shigellosis 3 5 13 5 2 28 Typhoid Fever 0 0 0 0 0 0 Yersinia enteritis 0 1 1 0 0 2 Subtotal 63 67 93 82 52 357 Influenza Flu Like Disease* 0 0 0 0 0 0 Influenza 37 63 49 231 278 658 Influenza, 2009 Novel* 0 0 0 0 0 0 Influenza, Novel 0 0 0 0 0 0 Subtotal 37 63 49 231 278 658 Meningitis Meningitis - Aseptic 6 21 11 9 13 60 Meningitis - Bacterial Other 1 3 2 3 7 16 Meningococcal Disease 0 1 0 0 0 1 Streptococcus pneumoniae, Inv 8 20 25 20 24 97 Subtotal 15 45 38 32 44 174 01-17-2019 1 of 5 Disease Group Disease 2014 2015 2016 2017 2018 Total Other Acute Flaccid Myelitis (AFM) 0 0 0 0 0 0 Anthrax 0 0 0 0 0 0 Blastomycosis 0 1 0 1 1 3 Botulism - Infant 0 0 0 0 0 0 Botulism - Other 0 0 0 0 0 0 Brucellosis 0 0 0 0 1 1 CP-CRE 0 0 0 0 5 5 Candida auris 0 0 0 0 0 0 Cholera 0 0 0 0 0 0 Coccidioidomycosis 0 1 1 0 1 3 Creutzfeldt-Jakob Disease 0 1 0 0 0 1 Cryptococcosis 0 0 0 2 1 3 Cyclosporiasis 1 0 0 0 0 1 Encephalitis, Post Chickenpox 0 0 0 0 0 0 Encephalitis, Post Mumps 0 0 0 0 0 0 Encephalitis, Post Other 0 1 0 0 0 1 Encephalitis, Primary 0 1 0 0 0 1 Gastrointestinal Illness 0 0 0 0 0 0 Guillain-Barre Syndrome 0 0 0 2 0 2 Hantavirus 0 0 0 0 0 0 Hantavirus, Other 0 0 0 0 0 0 Hantavirus, Pulmonary 0 0 0 0 0 0 Head Lice 0 0 0 0 0 0 Hemolytic Uremic Syndrome 0 0 0 0 0 0 Hemorrhagic Fever 0 0 0 0 0 0 Hepatitis - Unspecified 0 0 0 0 0 0 Histoplasmosis 7 10 10 8 6 41 Kawasaki 1 0 0 1 2 4 Legionellosis 1 1 2 3 3 10 Leprosy 0 0 0 0 0 0 Leptospirosis 0 0 0 0 0 0 Melioidosis 0 0 0 0 0 0 Novel Coronavirus 0 0 0 0 0 0 Plague 0 0 0 0 0 0 Psittacosis 0 0 0 0 1 1 Q Fever Acute 0 0 0 0 0 0 Q Fever Chronic 0 0 0 0 0 0 Q Fever* 0 0 1 0 1 2 Rabies Human 0 0 0 0 0 0 Reye Syndrome 0 0 0 0 0 0 Rheumatic Fever 0 0 0 0 0 0 Rubella - Congenital 0 0 0 0 0 0 01-17-2019 2 of 5 Disease Group Disease 2014 2015 2016 2017 2018 Total Other Staphylococcus Aureus Infect.* 0 0 0 0 0 0 Strep Throat 0 0 0 0 0 0 Streptococcal Dis, Inv, Grp A 1 3 9 10 8 31 Streptococcal Toxic Shock 0 0 0 0 0 0 Streptococcus pneumoniae, Drug Resistant 2 1 6 6 0 15 Toxic Shock 0 0 1 0 0 1 Trachoma 0 0 0 0 0 0 Trichinosis 0 0 0 0 0 0 Tularemia 0 0 0 0 0 0 Unusual Outbreak or Occurrence 1 1 2 7 4 15 VISA 0 1 0 0 0 1 VRSA 0 0 0 0 0 0 Vibriosis - Non Cholera 0 0 0 0 0 0 Subtotal 14 22 32 40 34 142 Rabies Animal Bite 0 2 1 209 186 398 Rabies Animal 7 2 2 0 2 13 Subtotal 7 4 3 209 188 411 STD Chancroid 0 0 0 0 0 0 Chlamydia (Genital) 431 495 547 535 536 2544 Gonorrhea 35 39 67 67 81 289 Granuloma Inguinale 0 0 0 0 0 0 Lymphogranuloma venereum 0 0 0 0 0 0 Syphilis - Congenital 0 0 0 0 0 0 Syphilis - Early Latent 1 1 1 3 1 7 Syphilis - Late Latent* 1 1 0 0 1 3 Syphilis - Late with Manifestations* 0 0 0 0 0 0 Syphilis - Latent of Unknown Duration* 0 0 0 0 0 0 Syphilis - Primary 0 0 2 1 2 5 Syphilis - Secondary 0 1 0 2 1 4 Syphilis - To Be Determined 0 0 0 0 0 0 Syphilis - Unknown Duration or Late 0 0 0 0 0 0 Subtotal 468 537 617 608 622 2852 Tuberculosis Latent Tuberculosis Infection 0 0 0 2 1 3 Nontuberculous Mycobacterium 0 0 2 4 14 20 Tuberculosis 0 0 0 1 0 1 Subtotal 0 0 2 7 15 24 VPD Chickenpox (Varicella) 14 16 21 16 5 72 Diphtheria 0 0 0 0 0 0 01-17-2019 3 of 5 Disease Group Disease 2014 2015 2016 2017 2018 Total VPD H. influenzae Disease - Inv. 3 2 6 2 6 19 Measles 0 0 0 0 0 0 Mumps 1 0 1 1 0 3 Pertussis 33 10 4 9 16 72 Polio 0 0 0 0 0 0 Rubella 0 0 0 0 0 0 Shingles 4 8 10 7 14 43 Tetanus 0 0 0 0 0 0 VZ Infection, Unspecified 4 8 9 4 4 29 Subtotal 59 44 51 39 45 238 Vectorborne Babesiosis 0 0 0 0 0 0 Chikungunya 0 0 0 1 0 1 Dengue Fever 0 0 0 0 0 0 Ehrlichiosis* 0 0 0 0 0 0 Ehrlichiosis, Anaplasma phagocytophilum 0 0 0 0 0 0 Ehrlichiosis, Ehrlichia chaffeensis 0 0 0 0 0 0 Ehrlichiosis, Ehrlichia ewingii 0 0 0 0 0 0 Ehrlichiosis, human granulocytic* 0 0 0 0 0 0 Ehrlichiosis, human monocytic* 0 0 0 0 0 0 Ehrlichiosis, human other/undetermined 0 0 0 0 0 0 Ehrlichosis human, other, unsp* 0 0 0 0 0 0 Encephalitis, California 0 0 0 0 0 0 Encephalitis, Eastern Equine 0 0 0 0 0 0 Encephalitis, Powassan 0 0 0 0 0 0 Encephalitis, St. Louis 0 0 0 0 0 0 Encephalitis, Western Equine 0 0 0 0 0 0 Lyme Disease 1 0 0 1 1 3 Malaria 0 0 0 0 0 0 Rickettsial Disease - Spotted Fever 0 0 0 3 0 3 Rickettsial Disease - Typhus 0 0 0 0 0 0 West Nile Virus 0 0 0 5 0 5 Yellow Fever 0 0 0 0 0 0 Zika 0 0 0 0 0 0 Subtotal 1 0 0 10 1 12 Viral HepatitisHepatitis A 1 2 0 2 8 13 Hepatitis B, Acute 0 1 0 1 1 3 Hepatitis B, Chronic 13 6 8 5 4 36 01-17-2019 4 of 5 Disease Group Disease 2014 2015 2016 2017 2018 Total Viral HepatitisHepatitis B, Perinatal 0 0 0 0 0 0 Hepatitis C, Acute 1 2 3 1 4 11 Hepatitis C, Chronic 82 82 108 104 88 464 Hepatitis C, Perinatal 0 0 0 0 0 0 Hepatitis C, Unknown* 0 1 0 0 0 1 Hepatitis D 0 0 0 0 0 0 Hepatitis E 0 1 0 0 0 1 Hepatitis Non A Non B 0 0 0 0 0 0 Subtotal 97 95 119 113 105 529 Total 764 879 1004 1371 1384 5402 01-17-2019 5 of 5.
Load more

Recommended publications
  • Parinaud's Oculoglandular Syndrome
    Tropical Medicine and Infectious Disease Case Report Parinaud’s Oculoglandular Syndrome: A Case in an Adult with Flea-Borne Typhus and a Review M. Kevin Dixon 1, Christopher L. Dayton 2 and Gregory M. Anstead 3,4,* 1 Baylor Scott & White Clinic, 800 Scott & White Drive, College Station, TX 77845, USA; [email protected] 2 Division of Critical Care, Department of Medicine, University of Texas Health, San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA; [email protected] 3 Medical Service, South Texas Veterans Health Care System, San Antonio, TX 78229, USA 4 Division of Infectious Diseases, Department of Medicine, University of Texas Health, San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA * Correspondence: [email protected]; Tel.: +1-210-567-4666; Fax: +1-210-567-4670 Received: 7 June 2020; Accepted: 24 July 2020; Published: 29 July 2020 Abstract: Parinaud’s oculoglandular syndrome (POGS) is defined as unilateral granulomatous conjunctivitis and facial lymphadenopathy. The aims of the current study are to describe a case of POGS with uveitis due to flea-borne typhus (FBT) and to present a diagnostic and therapeutic approach to POGS. The patient, a 38-year old man, presented with persistent unilateral eye pain, fever, rash, preauricular and submandibular lymphadenopathy, and laboratory findings of FBT: hyponatremia, elevated transaminase and lactate dehydrogenase levels, thrombocytopenia, and hypoalbuminemia. His condition rapidly improved after starting doxycycline. Soon after hospitalization, he was diagnosed with uveitis, which responded to topical prednisolone. To derive a diagnostic and empiric therapeutic approach to POGS, we reviewed the cases of POGS from its various causes since 1976 to discern epidemiologic clues and determine successful diagnostic techniques and therapies; we found multiple cases due to cat scratch disease (CSD; due to Bartonella henselae) (twelve), tularemia (ten), sporotrichosis (three), Rickettsia conorii (three), R.
    [Show full text]
  • Reportable Diseases and Conditions
    KINGS COUNTY DEPARTMENT of PUBLIC HEALTH 330 CAMPUS DRIVE, HANFORD, CA 93230 REPORTABLE DISEASES AND CONDITIONS Title 17, California Code of Regulations, §2500, requires that known or suspected cases of any of the diseases or conditions listed below are to be reported to the local health jurisdiction within the specified time frame: REPORT IMMEDIATELY BY PHONE During Business Hours: (559) 852-2579 After Hours: (559) 852-2720 for Immediate Reportable Disease and Conditions Anthrax Escherichia coli: Shiga Toxin producing (STEC), Rabies (Specify Human or Animal) Botulism (Specify Infant, Foodborne, Wound, Other) including E. coli O157:H7 Scrombroid Fish Poisoning Brucellosis, Human Flavivirus Infection of Undetermined Species Shiga Toxin (Detected in Feces) Cholera Foodborne Disease (2 or More Cases) Smallpox (Variola) Ciguatera Fish Poisoning Hemolytic Uremic Syndrome Tularemia, human Dengue Virus Infection Influenza, Novel Strains, Human Viral Hemorrhagic Fever (Crimean-Congo, Ebola, Diphtheria Measles (Rubeola) Lassa, and Marburg Viruses) Domonic Acid Poisoning (Amnesic Shellfish Meningococcal Infections Yellow Fever Poisoning) Novel Virus Infection with Pandemic Potential Zika Virus Infection Paralytic Shellfish Poisoning Plague (Specify Human or Animal) Immediately report the occurrence of any unusual disease OR outbreaks of any disease. REPORT BY PHONE, FAX, MAIL WITHIN ONE (1) WORKING DAY Phone: (559) 852-2579 Fax: (559) 589-0482 Mail: 330 Campus Drive, Hanford 93230 Conditions may also be reported electronically via the California
    [Show full text]
  • WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/05 (2006.01) A61P 31/02 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/CA20 14/000 174 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 4 March 2014 (04.03.2014) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 13/790,91 1 8 March 2013 (08.03.2013) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: LABORATOIRE M2 [CA/CA]; 4005-A, rue kind of regional protection available): ARIPO (BW, GH, de la Garlock, Sherbrooke, Quebec J1L 1W9 (CA). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (72) Inventors: LEMIRE, Gaetan; 6505, rue de la fougere, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Sherbrooke, Quebec JIN 3W3 (CA).
    [Show full text]
  • 2012 Case Definitions Infectious Disease
    Arizona Department of Health Services Case Definitions for Reportable Communicable Morbidities 2012 TABLE OF CONTENTS Definition of Terms Used in Case Classification .......................................................................................................... 6 Definition of Bi-national Case ............................................................................................................................................. 7 ------------------------------------------------------------------------------------------------------- ............................................... 7 AMEBIASIS ............................................................................................................................................................................. 8 ANTHRAX (β) ......................................................................................................................................................................... 9 ASEPTIC MENINGITIS (viral) ......................................................................................................................................... 11 BASIDIOBOLOMYCOSIS ................................................................................................................................................. 12 BOTULISM, FOODBORNE (β) ....................................................................................................................................... 13 BOTULISM, INFANT (β) ...................................................................................................................................................
    [Show full text]
  • Sexually Transmitted Diseases/Infections Chancroid
    Sexually Transmitted Diseases/Infections Chancroid Chancroid is a bacterial infection caused by Haemophilus ducreyi. It is spread by sexual contact and results in genital ulcers. Chancroid is a reportable genital ulcer condition that is rarely seen in North Carolina. When infection does occur, it is usually associated with sporadic outbreaks. Chancroid, as well as genital herpes and syphilis, is a risk factor in the transmission of HIV infection. Chancroid lesions may be difficult to distinguish from ulcers caused by genital herpes or syphilis. A physician must therefore diagnose the infection by excluding other diseases with similar symptoms. The combination of a painful genital ulcer and tender suppurative inguinal adenopathy suggests the diagnosis of chancroid. A probable diagnosis of chancroid, for both clinical and surveillance purposes, can be made if all of the following criteria are met: 1) the patient has one or more painful genital ulcers; 2) the patient has no evidence of T. pallidum infection by darkfield examination of ulcer exudate or by a serologic test for syphilis performed at least 7 days after onset of ulcers; 3) the clinical presentation, appearance of genital ulcers and, if present, regional lymphadenopathy are typical for chancroid; and 4) a test for HSV performed on the ulcer exudate is negative. A definitive diagnosis of chancroid requires the identification of H. ducreyi on special culture media that is not widely available from commercial sources; even when these media are used, sensitivity is less than 80 percent. No FDA- cleared PCR test for H. ducreyi is available in the United States, but such testing can be performed by clinical laboratories that have developed their own PCR test and have conducted a CLIA verification study.
    [Show full text]
  • Reportable Disease Surveillance in Virginia, 2013
    Reportable Disease Surveillance in Virginia, 2013 Marissa J. Levine, MD, MPH State Health Commissioner Report Production Team: Division of Surveillance and Investigation, Division of Disease Prevention, Division of Environmental Epidemiology, and Division of Immunization Virginia Department of Health Post Office Box 2448 Richmond, Virginia 23218 www.vdh.virginia.gov ACKNOWLEDGEMENT In addition to the employees of the work units listed below, the Office of Epidemiology would like to acknowledge the contributions of all those engaged in disease surveillance and control activities across the state throughout the year. We appreciate the commitment to public health of all epidemiology staff in local and district health departments and the Regional and Central Offices, as well as the conscientious work of nurses, environmental health specialists, infection preventionists, physicians, laboratory staff, and administrators. These persons report or manage disease surveillance data on an ongoing basis and diligently strive to control morbidity in Virginia. This report would not be possible without the efforts of all those who collect and follow up on morbidity reports. Divisions in the Virginia Department of Health Office of Epidemiology Disease Prevention Telephone: 804-864-7964 Environmental Epidemiology Telephone: 804-864-8182 Immunization Telephone: 804-864-8055 Surveillance and Investigation Telephone: 804-864-8141 TABLE OF CONTENTS INTRODUCTION Introduction ......................................................................................................................................1
    [Show full text]
  • HIV (Human Immunodeficiency Virus)
    TABLE OF CONTENTS AFRICAN TICK BITE FEVER .........................................................................................3 AMEBIASIS .....................................................................................................................4 ANTHRAX .......................................................................................................................5 ASEPTIC MENINGITIS ...................................................................................................6 BACTERIAL MENINGITIS, OTHER ................................................................................7 BOTULISM, FOODBORNE .............................................................................................8 BOTULISM, INFANT .......................................................................................................9 BOTULISM, WOUND .................................................................................................... 10 BOTULISM, OTHER ...................................................................................................... 11 BRUCELLOSIS ............................................................................................................. 12 CAMPYLOBACTERIOSIS ............................................................................................. 13 CHANCROID ................................................................................................................. 14 CHLAMYDIA TRACHOMATIS INFECTION .................................................................
    [Show full text]
  • Know Your Abcs: a Quick Guide to Reportable Infectious Diseases in Ohio
    Know Your ABCs: A Quick Guide to Reportable Infectious Diseases in Ohio From the Ohio Administrative Code Chapter 3701-3; Effective August 1, 2019 Class A: Diseases of major public health concern because of the severity of disease or potential for epidemic spread – report immediately via telephone upon recognition that a case, a suspected case, or a positive laboratory result exists. • Anthrax • Measles • Rubella (not congenital) • Viral hemorrhagic fever • Botulism, foodborne • Meningococcal disease • Severe acute respiratory (VHF), including Ebola virus • Cholera • Middle East Respiratory syndrome (SARS) disease, Lassa fever, Marburg • Diphtheria Syndrome (MERS) • Smallpox hemorrhagic fever, and • Influenza A – novel virus • Plague • Tularemia Crimean-Congo hemorrhagic infection • Rabies, human fever Any unexpected pattern of cases, suspected cases, deaths or increased incidence of any other disease of major public health concern, because of the severity of disease or potential for epidemic spread, which may indicate a newly recognized infectious agent, outbreak, epidemic, related public health hazard or act of bioterrorism. Class B: Disease of public health concern needing timely response because of potential for epidemic spread – report by the end of the next business day after the existence of a case, a suspected case, or a positive laboratory result is known. • Amebiasis • Carbapenemase-producing • Hepatitis B (perinatal) • Salmonellosis • Arboviral neuroinvasive and carbapenem-resistant • Hepatitis C (non-perinatal) • Shigellosis
    [Show full text]
  • Communicable Diseases Weekly Report
    Communicable Diseases Weekly Report Week 08, 21 February to 27 February 2021 In summary, we report: • Chancroid – one new case in a returned traveller • Rodent-borne disease risks • Novel coronavirus 2019 (COVID-19) • Summary of notifiable conditions activity in NSW For further information see NSW Health infectious diseases page. This includes links to other NSW Health infectious disease surveillance reports and a diseases data page for a range of notifiable infectious diseases. Chancroid One case of chancroid was notified this reporting week in a traveller returning from overseas. Chancroid is an acute sexually transmitted bacterial infection that causes painful genital ulcers. The condition is now rarely seen in Australia and only one other case has been notified in NSW during the past decade. Although the incidence of chancroid is decreasing globally, it is still reported in some regions within Africa, Asia, the Caribbean and South Pacific. Chancroid genital ulcer disease is a known risk factor for the transmission of HIV. The bacterium that causes chancroid, Haemophilus ducreyi, is usually transmitted through anal, oral, or vaginal sex with an infected person. After infection, one or more ulcers (sores) develop on the genitals or around the anus. Non-genital skin infections have also been reported globally, through non-sexual skin-to-skin contact with an infected person. The ulcers are usually painful, but rarely can be asymptomatic. Swelling in the groin (due to enlarged painful lymph nodes that can liquify and develop into buboes) can also occur. Other symptoms may include pain during sexual intercourse or while urinating. An infected person can spread the infection from their genital region to other parts of their body.
    [Show full text]
  • Annual Summary of Communicable Disease Reported to MDH, 2003
    MINNESOTA DEPARTMENT OF HEALTH DISEASE CONTROL N EWSLETTER Volume 32, Number 4 (pages 33-52) July/August 2004 Annual Summary of Communicable Diseases Reported to the Minnesota Department of Health, 2003 Introduction Minnesota Government Data Practices do not appear in Table 2 because the Assessment is a core public health Act (Section 13.38). Provisions of the influenza surveillance system is based function. Surveillance for communi- Health Insurance Portability and on reported outbreaks rather than on cable diseases is one type of ongoing Accountability Act (HIPAA) allow for individual cases. assessment activity. Epidemiologic routine communicable disease report- surveillance is the systematic collec- ing without patient authorization. Incidence rates in this report were tion, analysis, and dissemination of calculated using disease-specific health data for the planning, implemen- Since April 1995, MDH has participated numerator data collected by MDH and a tation, and evaluation of public health as one of the Emerging Infections standardized set of denominator data programs. The Minnesota Department Program (EIP) sites funded by the derived from U.S. Census data. of Health (MDH) collects disease Centers for Disease Control and Disease incidence may be categorized surveillance information on certain Prevention (CDC) and, through this as occurring within the seven-county communicable diseases for the program, has implemented active Twin Cities metropolitan area (Twin purposes of determining disease hospital- and laboratory-based surveil- Cities metropolitan area) or outside of it impact, assessing trends in disease lance for several conditions, including (Greater Minnesota). occurrence, characterizing affected selected invasive bacterial diseases populations, prioritizing disease control and food-borne diseases. Anaplasmosis efforts, and evaluating disease preven- Human anaplasmosis (HA) is the new tion strategies.
    [Show full text]
  • Disease Control Newsletter, July/August 2005
    MINNESOTA DEPARTMENT OF HEALTH D ISEASE C ONTROL N EWSLETTER Volume 33, Number 4 (pages 37-56) July/August 2005 Annual Summary of Communicable Diseases Reported to the Minnesota Department of Health, 2004 Introduction private and protected under the Incidence rates in this report were Assessment is a core public health Minnesota Government Data Practices calculated using disease-specific function. Surveillance for communi­ Act (Section 13.38). Provisions of the numerator data collected by MDH and a cable diseases is one type of assess­ Health Insurance Portability and standardized set of denominator data ment. Epidemiologic surveillance is the Accountability Act (HIPAA) allow for derived from U.S. Census data. systematic collection, analysis, and routine communicable disease report­ Disease incidence may be categorized dissemination of health data for the ing without patient authorization. as occurring within the seven-county planning, implementation, and evalua­ Twin Cities metropolitan area or outside tion of health programs. The Minnesota Since April 1995, MDH has participated of it (Greater Minnesota). Department of Health (MDH) collects as an Emerging Infections Program information on certain communicable (EIP) site funded by the Centers for Anaplasmosis diseases for the purposes of determin­ Disease Control and Prevention (CDC) Human anaplasmosis (HA) is the new ing disease impact, assessing trends in and, through this program, has imple­ nomenclature for the disease formerly disease occurrence, characterizing mented active hospital- and laboratory- known as human granulocytic affected populations, prioritizing control based surveillance for several condi­ ehrlichiosis. HA (caused by the efforts, and evaluating prevention tions, including selected invasive rickettsia Anaplasma phagocytophilum) strategies. Prompt reporting allows bacterial diseases and food-borne is transmitted to humans by Ixodes outbreaks to be recognized in a timely diseases.
    [Show full text]
  • NYC Health Code and Rules – Article 11- Reportable Diseases And
    ARTICLE 11 REPORTABLE DISEASES AND CONDITIONS §11.01 Definitions. §11.03 Diseases and conditions of public health interest that are reportable. §11.04 Report of First-Episode Psychosis §11.05 Reports. §11.07 Immunization Registry. §11.09 Blood Lead Reporting and Children's Blood Lead Registry. §11.10 Neonatal herpes simplex. §11.11 Confidentiality of reports and records. §11.13 Duty of physician to advise case, suspect case, carrier, suspect carrier and contact. §11.15 Control measures; duty to exclude; exclusion orders. §11.17 Control measures; duty to isolate; and isolation, quarantine and examination orders. §11.19 Typhoid and paratyphoid fever; exclusion. §11.21 Tuberculosis; reporting, examination, treatment, exclusion, removal and detention. §11.23 Removal and detention of cases, contacts and carriers who are or may be a danger to public health; other orders. §11.25 Reports and control of animal diseases communicable to humans. §11.27 Control of animals affected with rabies. §11.29 Rabies: compulsory vaccination. §11.31 Acts likely to spread disease prohibited. §11.33 Congenital Syphilis. §11.01 Definitions. When used in this article: (a) "Carrier" means an individual who, without showing any evidence of clinical disease, harbors and is capable of transmitting an infectious agent and may be a potential source of infection to others. (b) "Case" means, depending on the context, (1) an individual who, based on clinical, laboratory and/or epidemiologic evidence or other recognized public health criteria, has a disease or condition of public health interest that is reportable to the Department pursuant to this article or any other applicable law or regulation, or (2) an instance of such a reportable disease or condition occurring in an individual.
    [Show full text]